Home › Therapeutic areas › GI/Hepatology › Wilson's Disease
Wilson's Disease (2 companies)
Companies with an active program in Wilson's Disease.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| ETON | Eton Pharmaceuticals | GI/HepatologyInfectious Disease+3 Rare | 2 | Approved | $1.84B | 17 |
| PRME | Prime Medicine | GI/HepatologyRespiratory Rare | 1 | Phase 1 | $699M | 3 |
No companies match.